Moderna’s patent dispute with the U.S. government gets at a crucial question: control over how the drug is used
November 22, 2021 at 11:12 AM EST
Researchers calculate that the U.S. government provided $2.5 billion toward the development and commercialization of Moderna’s COVID-19 vaccine.
